xofluza
roche registration gmbh - baloxavir marboxil - influensa, human - antivirale midler til systemisk bruk - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre nervesystemet narkotika - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
wakix 4.5 mg
paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 4.5 mg
wakix 18 mg
paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 18 mg
palexia depot 50 mg
orifarm as - tapentadolhydroklorid - depottablett - 50 mg
palexia depot 100 mg
orifarm as - tapentadolhydroklorid - depottablett - 100 mg
palexia depot 150 mg
orifarm as - tapentadolhydroklorid - depottablett - 150 mg
palexia depot 200 mg
orifarm as - tapentadolhydroklorid - depottablett - 200 mg